# Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET

> **NCT06482307** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 10 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma (HNSCC)

## Interventions

- **DIAGNOSTIC_TEST:** [18F]-olaparib PET scan

## Key facts

- **NCT ID:** NCT06482307
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482307, "Molecular Imaging of DNA Damage Response by [18F]-Olaparib PET". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06482307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*